This product is a non-glycosylated human monoclonal antibody with glycosylation site in the Fc region. The antibody 29B11 with enhanced ADCC specifically binds human FAP and can be potentially used in the treatment of breast cancer, colon adenocarcinomas and NSCLC.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For Research Use Only. Not For Clinical Use.